Price Statement on 21st Century Cures Act

WASHINGTON, D.C. – House Budget Committee Chairman Tom Price, M.D. (GA-06) issued the following statement after the House of Representatives passed H.R. 6, the 21st Century Cures Act:
 
“Supporting medical innovation and the work of agencies like the NIH is critical to ensuring America remains a global leader in the fight to cure deadly diseases and develop breakthrough medical treatments. My colleagues who have worked diligently on this legislation ought to be commended for their dedication to that effort. At the same time, while the goals of this legislation are laudable, the fact that it creates a new mandatory spending program is both troubling and unnecessary. There’s no reason that these programs could not be authorized and then made, appropriately, a priority through the discretionary spending process.
 
“Before coming to Congress, I practiced medicine for over twenty years. The headquarters for the Centers for Disease Control & Prevention is based in the Atlanta area. Needless to say, I wholeheartedly support the pursuit of medical research and innovation. However, I cannot support this legislation as it stands. It sets an unacceptable precedent – particularly at a time when so much of our federal budget is already on auto-pilot, increasingly difficult to control and a significant risk to America’s fiscal well-being. I stand ready to work with my colleagues in advancing funding for health care research and to do so in a responsible manner.”